XML 72 R60.htm IDEA: XBRL DOCUMENT
v3.20.2

TAXES ON INCOME (Details) - USD ($) $ in Millions |  | 3 Months Ended | 9 Months Ended
--- | --- | --- | ---
Aug. 01, 2020 | Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019
Income Tax Disclosure [Abstract] |  |  |  |  |
Effective income tax rate |  | 23.70% | 22.90% | 23.90% | 23.40%
Share-based compensation, excess tax benefit, amount |  | $ 3 | $ 3 | $ 15 | $ 11
Income tax benefit due to the release of a valuation allowance associated with net operating loss carryforwards |  |  | $ 6 |  | $ 10
MACL |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Effective tax rate on remeasurement in acquisition | 11.80% |  |  |  |

X
- Definition Effective tax rate on remeasurement in acquisition + References No definition available. + Details
Name: | dgx_EffectiveTaxRateOnRemeasurementInAcquisition
Namespace Prefix: | dgx_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Income Tax Expense (Benefit) Due to Release of Valuation Allowance Associated With Net Operating Loss Carryforwards + References No definition available. + Details
Name: | dgx_IncomeTaxExpenseBenefitDueToReleaseOfValuationAllowanceAssociatedWithNetOperatingLossCarryforwards
Namespace Prefix: | dgx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319 + Details
Name: | us-gaap_EffectiveIncomeTaxRateContinuingOperations
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 740 -Section 35 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944 + Details
Name: | us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |